Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased by a...
Vaccinations01:51

Vaccinations

Overview
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions.

Clinical microbiology reviews·2026
Same author

Employing bacteriophages to combat cancer.

Biochimica et biophysica acta. Reviews on cancer·2025
Same author

Unlocking the biotechnological potential of Baltic microorganisms.

Frontiers in microbiology·2025
Same author

Reassessing the role of wild birds in the spread of antibiotic resistance: the white stork as a model species in studying populations from Central European river valley.

Microbiology spectrum·2025
Same author

Evaluation of the effectiveness and safety of bacteriophage vB_Sen-Miriam1 against Salmonella enterica in in vitro and in vivo models.

Virology·2025
Same author

Current and future directions in bacteriophage research for developing therapeutic innovations.

Scientific reports·2024

Related Experiment Video

Updated: Jul 9, 2026

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples
06:05

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples

Published on: June 14, 2024

Leptospirosis vaccines.

Zhijun Wang1, Li Jin, Alicja Wegrzyn

  • 1CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 200031, Shanghai, PR China. zjwang@shmu.edu.cn.

Microbial Cell Factories
|December 13, 2007
PubMed
Summary
This summary is machine-generated.

Developing effective leptospirosis vaccines remains challenging despite extensive research. This review examines various vaccine types, including recombinant outer membrane protein (OMP) and DNA vaccines, to guide future prevention strategies.

More Related Videos

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
08:51

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms

Published on: December 19, 2025

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
10:47

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Published on: July 1, 2011

Related Experiment Videos

Last Updated: Jul 9, 2026

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples
06:05

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples

Published on: June 14, 2024

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
08:51

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms

Published on: December 19, 2025

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
10:47

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Published on: July 1, 2011

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Microbiology

Background:

  • Leptospirosis is a significant zoonotic disease caused by pathogenic Leptospira spirochetes, posing risks to both humans and animals.
  • Despite decades of research and investment, current leptospirosis vaccines have shown limited success in clinical applications.
  • There is a critical need for effective vaccines to prevent leptospirosis through immunization of high-risk populations and animals.

Purpose of the Study:

  • To review recent advancements in various leptospirosis vaccine candidates.
  • To compare the efficacy and potential of different vaccine types against Leptospira.
  • To provide a resource for scientists to facilitate the development of novel leptospirosis vaccines.

Main Methods:

  • Comprehensive literature review of recent developments in leptospirosis vaccine research.
  • Analysis and comparison of different vaccine platforms, including recombinant outer membrane protein (OMP), lipopolysaccharide (LPS), inactivated, attenuated, and DNA vaccines.
  • Development of a vaccine ontology database as a tool for researchers.

Main Results:

  • Several vaccine strategies, including recombinant OMP, LPS, inactivated, attenuated, and DNA vaccines, have been explored for leptospirosis prevention.
  • A comparative analysis highlights the strengths and weaknesses of each vaccine approach.
  • A dedicated vaccine ontology database has been established to support ongoing research efforts.

Conclusions:

  • The review of diverse vaccine types offers insights into potential new methods for combating leptospirosis.
  • Further research and comparative studies are essential to overcome the challenges in developing successful clinical vaccines.
  • The vaccine ontology database serves as a valuable starting point for scientists in the field.